Keratoprosthesis Surgery: Evolution and Global Adaptations Authors:

Mohammad Soleimani

Ali R. Djalilian - adjalili@uic.edu

Abstract:

This is an Editorial and does not have an abstract. Please download the PDF or view the article in HTML.

References:

1. Basu S, Serna-Ojeda JC, Senthil S, Pappuru RR, Bagga B, Sangwan V. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year clinical outcomes in 134 cases of bilateral corneal blindness. Am J Ophthalmol 2019;205:175–183.

2. Rahmani S, Karimian F, Hassanpour K, Jafarinasab MR, Feizi S, Safi S, et al. Clinical outcomes of stage 2 (pivotal) use of a modified keratoprosthesis device (ORC-KPro) in patients with end-stage corneal blindness. J Ophthalmic Vis Res. 2024;19:297–305.

3. Gabriel BS, Robbins CB, Wisely CE, Gabriel RS, Daluvoy MB, Fekrat S. Incidence, risk factors, and treatment of retroprosthetic membranes following Boston keratoprosthesis eyes and the impact of glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 2024.